Pharmaceutical Market Access in 2026: Challenges and Solutions for the Middle East and GCC
Navigating GCC pharmaceutical market access in 2026 requires mastering diverse regulatory approvals, adapting pricing/reimbursement strategies, enhancing pharmacovigilance, and leveraging digital intelligence for compliance and growth.